000119997 001__ 119997
000119997 005__ 20240228135005.0
000119997 0247_ $$2doi$$a10.1038/cddis.2014.384
000119997 0247_ $$2pmid$$apmid:25255218
000119997 0247_ $$2pmc$$apmc:PMC4540206
000119997 0247_ $$2altmetric$$aaltmetric:2715462
000119997 037__ $$aDKFZ-2017-00585
000119997 041__ $$aeng
000119997 082__ $$a570
000119997 1001_ $$0P:(DE-HGF)0$$aNoack, J.$$b0$$eFirst author
000119997 245__ $$aA sphingosine kinase inhibitor combined with temozolomide induces glioblastoma cell death through accumulation of dihydrosphingosine and dihydroceramide, endoplasmic reticulum stress and autophagy.
000119997 260__ $$aLondon [u.a.]$$bNature Publishing Group$$c2014
000119997 3367_ $$2DRIVER$$aarticle
000119997 3367_ $$2DataCite$$aOutput Types/Journal article
000119997 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1490621952_10384
000119997 3367_ $$2BibTeX$$aARTICLE
000119997 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000119997 3367_ $$00$$2EndNote$$aJournal Article
000119997 520__ $$aGlioblastomas (GBMs) are very aggressive tumors with low chemosensitivity. The DNA-alkylating agent temozolomide (TMZ) is currently the most efficient chemotoxic drug for GBM therapy; however, many patients develop resistance to TMZ. Combining TMZ with another agent could present an improved treatment option if it could overcome TMZ resistance and avoid side effects. Sphingosine kinase inhibitors (SKIs) have emerged as anticancer agents. Sphingosine kinases are often overexpressed in tumors where their activity of phosphorylating sphingosine (Sph) contributes to tumor growth and migration. They control the levels of the pro-apoptotic ceramide (Cer) and Sph and of the pro-survival sphingosine-1 phosphate. In the present work, TMZ was combined with a specific SKI, and the cytotoxic effect of each drug alone or in combination was tested on GBM cell lines. The combination of sublethal doses of both agents resulted in the cell death potentiation of GBM cell lines without affecting astrocyte viability. It triggered a caspase-3-dependent cell death that was preceded by accumulation of dihydrosphingosine (dhSph) and dihydroceramide (dhCer), oxidative stress, endoplasmic reticulum stress, and autophagy. Autophagy was identified as the crucial switch that facilitated induction of this cell death potentiation. The sublethal dose of the inhibitor induced these stress events, whereas that of TMZ induced the destructive autophagy switch. Remarkably, neither Cer nor Sph, but rather the Cer intermediates, dhSph and dhCer, was involved in the cytotoxicity from the combination. Cell lines sensitive to the combination expressed low levels of the antioxidant enzyme glutathione peroxidase-1, indicating this enzyme as a potential marker of sensitivity to such treatment. This work shows for the first time a strong interaction between a SKI and TMZ, leading to a tumor cell-specific death induction. It further demonstrates the biological relevance of dihydrosphingolipids in cell death mechanisms and emphasizes the potential of drugs that affect sphingolipid metabolism for cancer therapy.
000119997 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000119997 588__ $$aDataset connected to CrossRef, PubMed,
000119997 650_7 $$2NLM Chemicals$$aAntineoplastic Agents
000119997 650_7 $$2NLM Chemicals$$aCeramides
000119997 650_7 $$2NLM Chemicals$$aEnzyme Inhibitors
000119997 650_7 $$2NLM Chemicals$$adihydroceramide
000119997 650_7 $$07GR28W0FJI$$2NLM Chemicals$$aDacarbazine
000119997 650_7 $$0EC 2.7.1.-$$2NLM Chemicals$$aPhosphotransferases (Alcohol Group Acceptor)
000119997 650_7 $$0EC 2.7.1.-$$2NLM Chemicals$$asphingosine kinase
000119997 650_7 $$0NGZ37HRE42$$2NLM Chemicals$$aSphingosine
000119997 650_7 $$0OWA98U788S$$2NLM Chemicals$$asafingol
000119997 650_7 $$0YF1K15M17Y$$2NLM Chemicals$$atemozolomide
000119997 7001_ $$0P:(DE-HGF)0$$aChoi, J.$$b1
000119997 7001_ $$0P:(DE-He78)027fe772631b4a2d7a45c439cdd75ff2$$aRichter, Karsten$$b2$$udkfz
000119997 7001_ $$0P:(DE-He78)bb6a7a70f976eb8df1769944bf913596$$aKopp-Schneider, Annette$$b3$$udkfz
000119997 7001_ $$0P:(DE-HGF)0$$aRégnier-Vigouroux, A.$$b4$$eLast author
000119997 773__ $$0PERI:(DE-600)2541626-1$$a10.1038/cddis.2014.384$$gVol. 5, no. 9, p. e1425 -$$n9$$pe1425 -$$tCell death & disease$$v5$$x2041-4889$$y2014
000119997 909CO $$ooai:inrepo02.dkfz.de:119997$$pVDB
000119997 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000119997 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000119997 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)027fe772631b4a2d7a45c439cdd75ff2$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000119997 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bb6a7a70f976eb8df1769944bf913596$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000119997 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000119997 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000119997 9141_ $$y2014
000119997 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCELL DEATH DIS : 2015
000119997 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000119997 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000119997 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000119997 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000119997 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000119997 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000119997 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000119997 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000119997 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000119997 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000119997 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000119997 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCELL DEATH DIS : 2015
000119997 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lBiostatistik$$x0
000119997 980__ $$ajournal
000119997 980__ $$aVDB
000119997 980__ $$aI:(DE-He78)C060-20160331
000119997 980__ $$aUNRESTRICTED